Friedreich Ataxia clinical trials

Explore recruiting friedreich ataxia clinical trials.

Recruiting friedreich ataxia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Friedreich Ataxia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Long-Term Open-Label Study to Assess the Safety and Efficacy of Vatiquinone in Patients With Friedreich Ataxia

Germany, France, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A double-blind, randomized, placebo-controlled trial to test the efficacy, safety and tolerability of Dimethyl Fumarate in Friedreich Ataxia (DMF-FA-201).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Friedreich Ataxia trials by city

Friedreich Ataxia in Toronto Friedreich Ataxia in Vancouver Friedreich Ataxia in Montreal Friedreich Ataxia in Calgary Friedreich Ataxia in Edmonton Friedreich Ataxia in Ottawa Friedreich Ataxia in Winnipeg Friedreich Ataxia in Quebec City Friedreich Ataxia in Hamilton Friedreich Ataxia in Kitchener Friedreich Ataxia in London Friedreich Ataxia in Halifax Friedreich Ataxia in New York Friedreich Ataxia in Los Angeles Friedreich Ataxia in Chicago Friedreich Ataxia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease